• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Myelodysplastic features developing in Philadephia-negative cells during imatinib mesylate therapy for CML: report of a new case.

作者信息

Mozziconacci M J, Caillères S, Maurice C, Vey N, Sainty D, Blaise D, Lafage-Pochitaloff M

出版信息

Leukemia. 2003 Sep;17(9):1901-2. doi: 10.1038/sj.leu.2403037.

DOI:10.1038/sj.leu.2403037
PMID:12970792
Abstract
摘要

相似文献

1
Myelodysplastic features developing in Philadephia-negative cells during imatinib mesylate therapy for CML: report of a new case.甲磺酸伊马替尼治疗慢性粒细胞白血病期间费城染色体阴性细胞出现骨髓增生异常特征：1例新病例报告
Leukemia. 2003 Sep;17(9):1901-2. doi: 10.1038/sj.leu.2403037.
2
Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones.在甲磺酸伊马替尼治疗期间发生的致命性骨髓增生异常综合征，其特征为出现复杂的费城染色体阴性克隆。
Leukemia. 2003 Mar;17(3):634-5. doi: 10.1038/sj.leu.2402842.
3
Clonal evolution in Philadelphia chromosome negative cells following successful treatment with Imatinib of a CML patient: clinical and biological features of a myelodysplastic syndrome.一名慢性粒细胞白血病患者经伊马替尼成功治疗后费城染色体阴性细胞的克隆进化：骨髓增生异常综合征的临床和生物学特征
Leukemia. 2004 Feb;18(2):361-2. doi: 10.1038/sj.leu.2403210.
4
[Clonal evolution of abnormal Philadelphia chromosome-negative cells after imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia].[甲磺酸伊马替尼治疗费城染色体阳性慢性髓性白血病患者后异常费城染色体阴性细胞的克隆进化]
Zhonghua Xue Ye Xue Za Zhi. 2005 Jan;26(1):23-6.
5
Reciprocal relationship between a Ph-negative clone with trisomy 8 associated with severe myelodysplasia and a Ph-positive clone following imatinib treatment in a patient with accelerated-phase chronic myelogenous leukemia (CML).一名加速期慢性粒细胞白血病（CML）患者中，伴有严重骨髓增生异常的8号染色体三体阴性克隆与伊马替尼治疗后的Ph阳性克隆之间的相互关系。
Am J Hematol. 2004 Dec;77(4):420. doi: 10.1002/ajh.20226.
6
The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells.费城染色体阴性细胞中存在克隆性细胞遗传学异常的慢性髓性白血病患者的预后。
Cancer. 2007 Oct 1;110(7):1509-19. doi: 10.1002/cncr.22936.
7
Clonal chromosomal abnormalities in the Philadelphia chromosome negative cells of chronic myeloid leukemia patients treated with imatinib.
Leukemia. 2004 Jun;18(6):1140-2. doi: 10.1038/sj.leu.2403361.
8
The first case of Philadelphia chromosome-negative acute promyelocytic leukemia following imatinib for chronic myelogenous leukemia.伊马替尼治疗慢性粒细胞白血病后出现的首例费城染色体阴性急性早幼粒细胞白血病病例。
Cancer Genet. 2012 Mar;205(3):124-7. doi: 10.1016/j.cancergen.2012.01.006.
9
Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia-positive chronic myeloid leukemia: two cases with a different outcome.在费城染色体阳性慢性髓性白血病的伊马替尼治疗过程中发生的伴有严重骨髓发育异常的7号染色体单体：两例不同结局的病例
Am J Hematol. 2007 Sep;82(9):849-51. doi: 10.1002/ajh.20859.
10
Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with Imatinib.
Leukemia. 2003 Feb;17(2):465-7. doi: 10.1038/sj.leu.2402791.

引用本文的文献

1
[Philadelphia chromosome-negative myeloid neoplasms in patients with Philadelphia chromosome-positive chronic myeloid leukemia during tyrosine kinase inhibtor-therapy].[酪氨酸激酶抑制剂治疗期间费城染色体阳性慢性髓性白血病患者中的费城染色体阴性髓系肿瘤]
Zhonghua Xue Ye Xue Za Zhi. 2019 Jul 14;40(7):547-553. doi: 10.3760/cma.j.issn.0253-2727.2019.07.003.
2
Secondary myelodysplastic syndrome in a patient with Philadelphia-positive acute lymphoblastic leukemia after achieving a major molecular response with hyperCVAD plus imatinib mesylate.在一名费城染色体阳性急性淋巴细胞白血病患者通过hyperCVAD加甲磺酸伊马替尼实现主要分子反应后发生的继发性骨髓增生异常综合征
Leuk Res. 2008 Sep;32(9):1468-71. doi: 10.1016/j.leukres.2008.02.001. Epub 2008 Mar 19.